Factors Associated with Opioid-Related Fatal and Non-fatal Overdose

Size: px
Start display at page:

Download "Factors Associated with Opioid-Related Fatal and Non-fatal Overdose"

Transcription

1 Factrs Assciated with Opiid-Related Fatal and Nn-fatal Overdse Understanding the factrs assciated with piid-related fatal and nn-fatal verdse and can help practitiners assess, plan fr, and select interventins t address them. Researchers have identified a variety f factrs that place individuals at increased risk fr piid verdse (and death in the event f an verdse). These can be rganized int the fllwing categries: Opiid Use and Misuse Ability t Prcess Opiids Chrnic Pain and Mental Health Opiid Access and Supply Opiid Knwledge and Perceptins Nn-fatal Overdse OPIOID USE AND MISUSE Bth medical and illicit use f piids can place individuals a risk f fatal and nn-fatal verdse. Risk factrs assciated with the medical use f prescriptin piids include: Prescriptins that are lng-term, r fr high dses r lng-acting piids Having cncurrent prescriptins (fr example, fr multiple piids r fr bth piids and benzdiazepines) Risk factrs assciated with the illicit use f any piids include: Nn-medical use f prescriptin piids Use f herin and ther nn-prescriptin piids Illicit use f piids in cmbinatin with ther cntrlled substances (similar t medical use) PAGE 1 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS I/HHSS T. Fr training use nly. March 21, PAGE 1

2 Finally, use f piids alne (withut ther individuals arund t respnd) is assciated with increased risk f death in the event f an verdse. ABILITY TO PROCESS OPIOIDS An individual s ability t physically prcess an piid is influenced by several factrs that can increase ne s risk fr fatal r nn-fatal verdse: piid dependence, changes in piid tlerance, and cmprmised physical health. Opiid dependence, a physical adaptatin t piids that prduces withdrawal symptms when piid use stps, may lead t piid misuse r additin, which is assciated with increased verdse risk Risk factrs assciated with piid tlerance (the bdy s ability t prcess and experience the effects f a certain amunt f a substance) include: An increase in tlerance (needing mre f a drug in rder t experience the same effect) Decrease in tlerance with time away frm use (due t hspitalizatin, treatment, r incarceratin) Risk factrs assciated with physical health prblems include: A cmprmised immune system Pulmnary dysfunctin (including lung damage and disrders such as asthma, emphysema, r sleep apnea) Liver dysfunctin CHRONIC PAIN AND MENTAL HEALTH In additin t the physical health factrs that may influence an individual s ability t prcess piids, several ther physical and mental health issues as assciated with an increased risk fr piidrelated fatal and nn-fatal verdse. Chrnic pain, defined as pain that lasts lnger than 3 mnths r past the time an injury is expected t heal Mental health disrders, including depressin, anxiety, and/r substance use disrders Risk factrs assciated with adverse life experiences include: Having witnessed a family member verdse Financial struggles, including unemplyment Hmelessness PAGE 2 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS I/HHSS T. Fr training use nly. March 21, PAGE 2

3 OPIOID ACCESS AND SUPPLY Factrs that increase the availability f prescriptin and nn-prescriptin piids such as piid prescribing practices, diversin f prescriptin piids, and changes in the lcal drug supply as assciated with increased risk fr fatal and nn-fatal verdse. Risk factrs assciated with piid prescribing practices include: Increases in piid dsage and/r duratin f use, and number f pills prescribed (that is, days supply) Increases in the number f piid prescriptins written The diversin f prescriptin piids r redirectin f cntrlled substances frm their lawful purpse t illicit use is assciated with increased risk fr piid-related verdse. Prescriptin drugs can be diverted thrugh peple such as: Friends r relatives Healthcare prviders Drug dealers Risk factrs assciated with changes in the lcal drug supply include: Increases in the availability and decreases in the cst f herin Increases in the purity f herin Increases in the number f street drugs, including herin, testing psitive fr fentanyl and ther ptent piids OPIOID KNOWLEDGE AND PERCEPTIONS An individual s lack f knwledge abut piids and risks assciated with their misuse, including verdse, and their perceptins twards these drugs can place them at increased risk fr verdse. Risk factrs assciated with piid knwledge and perceptins include: A lack f understanding r awareness f verdse risks (such as the risks assciated with using piids and ther substances cncurrently) A lw perceptin f the harms assciated with piids, specifically prescriptin piids NON-FATAL OVERDOSE Experiencing a nn-fatal piid verdse in the past increases peple s risk f suffering a fatal verdse in the future. PAGE 3 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS I/HHSS T. Fr training use nly. March 21, PAGE 3

4 Risk factrs assciated with nn-fatal verdse include: The specific factrs that caused the initial verdse, including high-risk piid misuse. Any physical health prblems caused by the verdse itself, which may include damage t the brain, heart, liver, r kidneys. REFERENCES Baumblatt, J. A. G., Wiedeman, C., Dunn, J. R., Schaffner, W., Paulzzi, L. J., & Jnes, T. F. (2014). High-risk use by patients prescribed piids fr pain and its rle in verdse deaths. JAMA Internal Medicine, 174(5), Betts, K. S., McIlwraith, F., Dietze, P., Whittaker, E., Burns, L., Cgger, S., & Alati, R. (2015). Can differences in the type, nature r amunt f plysubstance use explain the increased risk f nn-fatal verdse amng psychlgically distressed peple wh inject drugs? Drug and Alchl Dependence, 154, Bhnert, A. S. B., Valenstein, M., Bair, M. J., Ganczy, D., McCarthy, J. F., Ilgen, M. A., & Blw, F. C. (2011). Assciatin Between Opiid Prescribing Patterns and Opiid Overdse-Related Deaths. JAMA, 305(13), Bnar, E. E., & Bhnert, A. S. (2016). Perceived severity f and susceptibility t verdse amng injectin drug users: Relatinships with verdse histry. Substance Use & Misuse, 51(10), Green, T. C., Black, R., Grimes Serran, J. M., Budman, S. H., & Butler, S. F. (2011). Typlgies f prescriptin piid use in a large sample f adults assessed fr substance abuse treatment. PLOS ONE, 6(11), e Jhnsn, E. M., Lanier, W. A., Merrill, R. M., Crk, J., Prucznik, C. A., Rlfs, R. T., & Sauer, B. (2013). Unintentinal prescriptin piid-related verdse deaths: descriptin f decedents by next f kin r best cntact, Utah, Jurnal f General Internal Medicine, 28(4), Kinner, S. A., Milly, M. J., Wd, E., Qi, J., Zhang, R., & Kerr, T. (2012). Incidence and risk factrs fr nn-fatal verdse amng a chrt f recently incarcerated illicit drug users. Addictive Behavirs, 37(6), Neira-León, M., Barri, G., Brav, M. J., Brugal, M. T., de la Fuente, L., Dming-Salvany, A., Pulid, J., Sants, S., & Prject Itinere Grup. (2011). Infrequent piid verdse risk reductin behaviurs amng yung adult herin users in cities with wide cverage f HIV preventin prgrammes. Internatinal Jurnal f Drug Plicy, 22(1), Peirce, G. L., Smith, M. J., Abate, M. A., & Halversn, J. (2012). Dctr and pharmacy shpping fr cntrlled substances. Medical Care, 50(6), Riley, E. D., Evans, J. L., Hahn, J. A., Bricen, A., Davidsn, P. J., Lum, P. J., & Page, K. (2016). A lngitudinal study f multiple drug use and verdse amng yung peple wh inject drugs. American Jurnal f Public Health, 106(5), Siegler, A., Tuazn, E., Bradley O Brien, D., & Pane, D. (2014). Unintentinal piid verdse deaths in New Yrk City, : A place-based apprach t reduce risk. Internatinal Jurnal f Drug Plicy, 25(3), Silva, K., Schrager, S. M., Kecjevic, A., & Lankenau, S. E. (2013). Factrs assciated with histry f nn-fatal verdse amng yung nnmedical users f prescriptin drugs. Drug and Alchl Dependence, 128(1-2), PAGE 4 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS I/HHSS T. Fr training use nly. March 21, PAGE 4

5 Yarbrugh, B. J., Stumb, S. P., Janff, S. L., Yarbrugh, M. T., McCarty, D., Chilcat, H. D., Cplan, P. M., & Green, C. A. (2016 ). Understanding piid verdse characteristics invlving prescriptin and illicit piids: A mixed methds analysis. Drug and Alchl Dependence, 167, Yang, Z., Wilsey, B., Bhm, M., Weyrich, M., Ry, K., Ritley, D., Jnes, C., & Melnikw, J. (2015). Defining risk f prescriptin piid verdse: pharmacy shpping and verlapping prescriptins amng lng-term piid users in medicaid. The Jurnal f Pain, 16(5), Zedler, B., Xie, L., Wang, L., Jyce, A., Vick, C., Karibury, F., Rajan, P., Baser, O., & Murrelle, L. (2014). Risk factrs fr serius prescriptin piid-related txicity r verdes amng Veterans Health Administratin patients. Pain Medicine, 15(11), Zedler, B., Xie, L., Wang, L., Jyce, A., Vick, C., Brigham, J., Karibury, F., Baser, O., & Murrelle, L. (2015). Develpment f a risk index fr serius prescriptin piid-induced respiratry depressin r verdse in Veterans Health Administratin patients. Pain Medicine, 16(8), PAGE 5 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS I/HHSS T. Fr training use nly. March 21, PAGE 5

2017 Optum, Inc. All rights reserved BH1124_112017

2017 Optum, Inc. All rights reserved BH1124_112017 1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases

More information

Thank you for committing to engage pharmacists regarding the incredible opportunity for them to prevent opioid overdose deaths by providing naloxone!

Thank you for committing to engage pharmacists regarding the incredible opportunity for them to prevent opioid overdose deaths by providing naloxone! Thank yu fr cmmitting t engage pharmacists regarding the incredible pprtunity fr them t prevent piid verdse deaths by prviding nalxne! If yu encunter cmplicated questins that yu are unable t answer, please

More information

The Role of Prevention in Addressing Opioid Overdose

The Role of Prevention in Addressing Opioid Overdose CAPT TRAINING October 10, 2017 The Role of Prevention in Addressing Opioid Overdose Trainers: Erin Haas, MPH, CAPT Associate Hayden D. Center, Jr., Ph.D., L.P.C, CAPT Associate Technical Information This

More information

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain Pennsylvania Guidelines n the Use f Opiids t Treat Chrnic Nncancer Pain Chrnic pain is a majr health prblem in the United States, ccurring with a pintprevalence f abut ne-third f the US ppulatin.(1) Mre

More information

Attachment 3. Efforts to Address the Opioid Epidemic in Clark County

Attachment 3. Efforts to Address the Opioid Epidemic in Clark County Attachment 3 Effrts t Address the Opiid Epidemic in Clark Cunty Overview Backgrund Current wrk SNHD Challenges Next Steps Backgrund Drug verdses are nw the leading cause f death amng Americans under 50

More information

Orange County Heroin Task Force: A targeted approach to improving outcomes

Orange County Heroin Task Force: A targeted approach to improving outcomes Orange Cunty Herin Task Frce: A targeted apprach t imprving utcmes Christpher Hunter, M.D., Ph.D. Directr, Orange Cunty Health Services Department Assciate Medical Directr, Orange Cunty EMS System Cntents

More information

Influenza (Flu) Fact Sheet

Influenza (Flu) Fact Sheet Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder

More information

Medication Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets

Medication Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets Medicatin Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets IMPORTANT: D nt use ABSTRAL unless yu are regularly using anther piid pain medicine arund-the-clck fr at least ne week r lnger fr yur

More information

US Public Health Service Clinical Practice Guidelines for PrEP

US Public Health Service Clinical Practice Guidelines for PrEP Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S

More information

Medication Assisted Treatment for Opioid Use Disorder in Rural Colorado

Medication Assisted Treatment for Opioid Use Disorder in Rural Colorado Medicatin Assisted Treatment fr Opiid Use Disrder in Rural Clrad Why is piid use disrder getting s much attentin? Opiid Use Disrder (OUD) has seen an epidemic rise in the United States ver the past decade.

More information

Medicare Advantage 2019 Advance Notice Part 1 21 st Century Cures Act Methodological Changes

Medicare Advantage 2019 Advance Notice Part 1 21 st Century Cures Act Methodological Changes Medicare Advantage 2019 Advance Ntice Part 1 21 st Century Cures Act Methdlgical Changes Review f Relevant Prvisins with Expert Insight January 2018 PULSE8 is privileged t bring yu a summary f key Medicare

More information

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII) Medicatin Guide MORPHINE SULFATE (mr-pheen) Oral Slutin (CII) IMPORTANT: Keep Mrphine Sulfate Oral Slutin in a safe place away frm children. Accidental use by a child is a medical emergency and can cause

More information

Opioid Analgesics PA Request Provider Checklist

Opioid Analgesics PA Request Provider Checklist WVP Health Authrity Updated 05-12-2015 Opiid Analgesics PA Request Prvider Checklist *** If pssible, please include the fllwing infrmatin with PA requests fr piid analgesics. Including the requested infrmatin

More information

EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION

EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION The Bitechnlgy Innvatin Organizatin (BIO) and ur member

More information

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder? updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health

More information

Risk factors in health and disease

Risk factors in health and disease Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk

More information

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

Completing the NPA online Patient Safety Incident Report form: 2016

Completing the NPA online Patient Safety Incident Report form: 2016 Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject

More information

Related Policies None

Related Policies None Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER

More information

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline) Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting

More information

Improving Surveillance and Monitoring of Self-harm in Irish Prisons

Improving Surveillance and Monitoring of Self-harm in Irish Prisons HSE Mental Health Divisin Stewart s Hspital, Palmerstwn, Dublin 20 Tel: 01 6201670 Email: inf@nsp.ie www.nsp.ie Imprving Surveillance and Mnitring f Self-harm in Irish Prisns Prject Scpe Dcument 8 th June

More information

3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program?

3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program? 3903 Fair Ridge Drive, Suite 209, Fairfax, VA 22033 44121 Harry Byrd Hwy, Suite 285, Ashburn, VA 220147 *Hw did yu hear abut ur prgram? Patient Histry Patient Name: First Middle: Last: Address: City: State:

More information

Methadone Maintenance Treatment for Opioid Dependence

Methadone Maintenance Treatment for Opioid Dependence POLICY STATEMENT Methadne Maintenance Treatment fr Opiid Dependence APPROVED BY COUNCIL: May 2010 PUBLICATION DATE: Dialgue, Issue 2, 2010 Disclaimer: As f May 19, 2018 physicians n lnger require an exemptin

More information

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED

More information

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache Measure Descriptin All patients diagnsed with migraine headache r cervicgenic headache wh had a headache management

More information

The data refer to persons aged between 15 and 54.

The data refer to persons aged between 15 and 54. Drug-related hspital stays in Australia 1993-2005 Prepared by Amanda Rxburgh and Luisa Degenhardt, Natinal Drug and Alchl Research Centre Funded by the Australian Gvernment Department f Health and Ageing

More information

Top 10 Causes of Disability

Top 10 Causes of Disability Tp 10 Causes f Disability Disability can happen t anyne, f any age. Thugh sme may be the result f accidents r injuries that are unavidable, many disabilities are the result f diseases and health cnditins

More information

THE DANISH HARM REDUCTION MODEL

THE DANISH HARM REDUCTION MODEL THE DANISH HARM REDUCTION MODEL OUTLINE 1. Drug use and drug prblems in Denmark. 2. Danish drug plicy. 3. Danish harm reductin plicy. 4. Drug cnsumptin facilities. DANISH DRUG POLICY Drug plicy can be

More information

Introduction. Forensic toxicology helps determine cause-and-effect relationships. Toxic or lethal effects from that exposure. between.

Introduction. Forensic toxicology helps determine cause-and-effect relationships. Toxic or lethal effects from that exposure. between. 1 Drugs and Txins Intrductin Frensic txiclgy helps determine cause-and-effect relatinships between Expsure t a drug r ther substance and Txic r lethal effects frm that expsure 2 Frensic Science: Fundamentals

More information

Supporting Psychosocial Health and Resilience in Liberia. Japanese Social Development Fund The World Bank 4 March, 2015

Supporting Psychosocial Health and Resilience in Liberia. Japanese Social Development Fund The World Bank 4 March, 2015 Supprting Psychscial Health and Resilience in Liberia Japanese Scial Develpment Fund The Wrld Bank 4 March, 2015 Summary Cntext Mental Heath and Psychscial Impact f EVD Prject Overview Prject Objectives

More information

Ontario s Referral and Listing Criteria for Adult Lung Transplantation

Ontario s Referral and Listing Criteria for Adult Lung Transplantation Ontari s Referral and Listing Criteria fr Adult Lung Transplantatin Versin 2.0 Trillium Gift f Life Netwrk Adult Lung Transplantatin Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The patient referral

More information

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009 CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral

More information

Significance of Chronic Kidney Disease in 2015

Significance of Chronic Kidney Disease in 2015 1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care

More information

Original Policy Date 12:2013

Original Policy Date 12:2013 MP 5.01.18 Xlair (Omalizumab) Medical Plicy Sectin Prescriptin Drugs Issu12:2013e 4:2006 Original Plicy Date 12:2013 Last Review Status/Date Lcal plicy/12:2013 Return t Medical Plicy Index Disclaimer Our

More information

Cardiac Rehabilitation Services

Cardiac Rehabilitation Services Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin

More information

Solid Organ Transplant Benefits to Change for Texas Medicaid

Solid Organ Transplant Benefits to Change for Texas Medicaid Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a

More information

454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place

454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place MEDICATION GUIDE ZUBSOLV (Zub-slve) (buprenrphine and nalxne) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place away frm children. Accidental use by a child is a medical emergency and

More information

MINISTRY OF HEALTH INFORMATION BRIEFING NOTE

MINISTRY OF HEALTH INFORMATION BRIEFING NOTE Cliff # 980489 MINISTRY OF HEALTH INFORMATION BRIEFING NOTE. PREPARED FOR: Graham Whitmarsh, Deputy Minister, Ministry f Health Heather Davidsn, ADM, Planning and Innvatin Divisin FOR INFORMATION TITLE:

More information

Young Hackney Substance Misuse Service

Young Hackney Substance Misuse Service Yung Hackney Substance Misuse Service Needs Assessment The Needs Assessment carried ut in 2014 highlighted the fllwing key areas fr imprvement and develpment: Lack f existing service prvisin fr 19 25 year

More information

STRATEGIC PLAN APRIL 2018

STRATEGIC PLAN APRIL 2018 STRATEGIC PLAN APRIL 2018 LANCASTER COUNTY JOINING FORCES INFORMATION DISCLAIMER Lancaster Cunty Jining Frces emphasizes the principles f transparency, accuntability, cllabratin, and partnership. We are

More information

The policy was formulated through consultation between members of staff, governors, parents and pupils.

The policy was formulated through consultation between members of staff, governors, parents and pupils. VALENCE PRIMARY SCHOOL Fd and Drink Plicy INTRODUCTION Valence Primary Schl is dedicated t prmting healthy lifestyles and prviding an envirnment that prmtes healthy eating and drinking, enabling pupils

More information

S.K.J Construction Ltd Groundwork & Civil Engineering

S.K.J Construction Ltd Groundwork & Civil Engineering S.K.J Cnstructin Ltd Grundwrk & Civil Engineering SUBSTANCE MISUSE POLICY 1 2 SUBSTANCE MISUSE POLICY 1 INTRODUCTION Plicy Aims Frm the viewpint f health and safety at wrk, SKJ Cnstructin Ltd (the Cmpany)

More information

FTD RESEARCH: The Value of Studies and Opportunities for Involvement

FTD RESEARCH: The Value of Studies and Opportunities for Involvement FTD RESEARCH: The Value f Studies and Opprtunities fr Invlvement Sarah Lawrence, MS Research Prgram Manager Ann Fishman, MBA Sr. Research Crdinatr Weiyi Mu, ScM Genetic Cunselr Suzanne Dana Spuse/Caregiver

More information

Prescribing Safely to Prevent Misuse & Diversion

Prescribing Safely to Prevent Misuse & Diversion Patient-Prvider Agreement fr Onging Use f Cntrlled Medicatin BIRTHDATE: NAME: The use f the fllwing medicine(s) (list medicine names) Is nly ne part f my treatment fr. Primary Prescribing Dctr: What shuld

More information

Ill Health. Unit reference number: L/616/7295 Level: 3. Credit value: 3 Guided learning hours: 16. Unit summary

Ill Health. Unit reference number: L/616/7295 Level: 3. Credit value: 3 Guided learning hours: 16. Unit summary Unit 11: Understand Mental Ill Health Unit reference number: L/616/7295 Level: 3 Unit type: Optinal Credit value: 3 Guided learning hurs: 16 Unit summary Mental ill health culd be ne f the mst serius health

More information

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

Standard Statement Content Words Essential Questions Knowledge and/or Skill Topic Assessment A. Analyze factors that impact growth and development

Standard Statement Content Words Essential Questions Knowledge and/or Skill Topic Assessment A. Analyze factors that impact growth and development Curse: Health Grade: Grade 7 State Standard: 10.1.9 Cncepts f Health Time Frame: 20-22 Lessns Standard Statement Cntent Wrds Essential Questins Knwledge and/r Skill Tpic Assessment A. Analyze factrs that

More information

CHAPTER 2. HEALTH SERVICES

CHAPTER 2. HEALTH SERVICES CHAPTER 2. HEALTH SERVICES 2.1 Treatment f substance use disrders within health services Thmas F Babr and Kerstin Stenius Overview Since the end f the Secnd Wrld War there has been a cnsistent grwth f

More information

State Health Improvement Plan Choosing Priorities, Creating a Plan. DHHS DPH - SHIP Priorities (Sept2016) 1

State Health Improvement Plan Choosing Priorities, Creating a Plan. DHHS DPH - SHIP Priorities (Sept2016) 1 State Health Imprvement Plan 2017-2021 Chsing Pririties, Creating a Plan DHHS DPH - SHIP Pririties (Sept2016) 1 Creating a Plan: 2017-2021 SHIP Welcme! Wh s here? What is the State Health Imprvement Plan

More information

Cancer Association of South Africa (CANSA)

Cancer Association of South Africa (CANSA) Cancer Assciatin f Suth Africa (CANSA) Fact Sheet and Psitin Statement n Cannabis in Suth Africa Intrductin Cannabis is a drug that cmes frm Indian hemp plants such as Cannabis sativa and Cannabis indica.

More information

Advantage EAP Employee Assistance Program

Advantage EAP Employee Assistance Program Advantage EAP Emplyee Assistance Prgram July 2014 In This Issue What might we face? Symptms f SAD Seasnal changes in biplar disrder Tips fr cmbating summer truble When t seek help Tips fr helping thse

More information

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training Iwa Early Peridic Screening, Diagnsis and Treatment Care fr Kids Prgram Prvider Training The Early Peridic Screening, Diagnsis and Treatment (EPSDT) Care fr Kids prgram is Iwa s Medicaid prgram fr children.

More information

PART III: CONSUMER INFORMATION

PART III: CONSUMER INFORMATION IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr ZERIT Stavudine This leaflet is Part III f a three-part Prduct Mngaph published when ZERIT was apprved fr sale in Canada and is designed specifically

More information

Obesity/Morbid Obesity/BMI

Obesity/Morbid Obesity/BMI Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin

More information

These are medical emergencies that can cause death. If possible, remove OTFC from the mouth.

These are medical emergencies that can cause death. If possible, remove OTFC from the mouth. MEDICATION GUIDE Oral Transmucsal Fentanyl Citrate (OTFC) CII (fentanyl citrate) ral transmucsal lzenge 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1200 mcg, 1600 mcg IMPORTANT: D nt use Oral Transmucsal Fentanyl

More information

Policy. Medical Policy Manual Approved: Do Not Implement Until 1/1/18. Applied Behavioral Analysis (ABA)

Policy. Medical Policy Manual Approved: Do Not Implement Until 1/1/18. Applied Behavioral Analysis (ABA) Plicy Medical Plicy Manual Apprved: D Nt Implement Until 1/1/18 Applied Behaviral Analysis (ABA) This medical plicy will apply t self-funded grups upn their renewal, beginning 1/1/18. Des nt apply t BlueCare.

More information

Flu Season Key Points ( )

Flu Season Key Points ( ) 2014-2015 Flu Seasn Key Pints (10-31-14) Cntents Overarching Framewrk f CDC Influenza Messaging... 3 Take 3 Messages... 3 Statements fr General Audiences... 4 Disease... 4 Vaccinatin... 6 Vaccinatin Timing...

More information

Human papillomavirus (HPV) refers to a group of more than 150 related viruses.

Human papillomavirus (HPV) refers to a group of more than 150 related viruses. HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between

More information

EAST VALLEY DERMATOLOGY CENTER

EAST VALLEY DERMATOLOGY CENTER EAST VALLEY DERMATOLOGY CENTER Adult and Pediatric Dermatlgy VALLEY SKIN CANCER SURGERY PATIENT INFORMATION RECORD Please Use Black Ink Only Patient Infrmatin Patient s Name Last First Middle Initial Address

More information

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health

More information

Psychological aspects of breast cancer. Dr Caroline Dancyger & Dr Esther Hansen

Psychological aspects of breast cancer. Dr Caroline Dancyger & Dr Esther Hansen Psychlgical aspects f breast cancer Dr Carline Dancyger & Dr Esther Hansen Cmmn acrss all cancers Adjustment as the nrm Diagnsis End f active treatment r Discharge Palliative Care Recurrence distress t

More information

Annex III. Amendments to relevant sections of the Product Information

Annex III. Amendments to relevant sections of the Product Information Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t

More information

FIGHT DEMENTIA ACTION PLAN

FIGHT DEMENTIA ACTION PLAN FIGHT DEMENTIA ACTION PLAN DEMENTIA IS A HEALTH PRIORITY Dementia will be the majr health prblem f this century. Over ne millin Australians are already affected by the disease themselves r are caring fr

More information

MEDICATION GUIDE. (Interferon alfa-2b)

MEDICATION GUIDE. (Interferon alfa-2b) MEDICATION GUIDE INTRON A (In-trn-aye) (Interfern alfa-2b) Read this Medicatin Guide befre yu start taking INTRON A, and each time yu get a refill. There may be new infrmatin. This infrmatin des nt take

More information

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS 1 SECTION 1 INTRODUCTION: EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS The Nature Of Assessment The Definitin Of Assessment The Difference Between Testing, Measurement And Evaluatin Characteristics

More information

PATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems.

PATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems. PATIENT INFORMATION capsules, fr ral use fr ral suspensin What is TAMIFLU? TAMIFLU is a prescriptin medicine used t: treat the flu (influenza) in peple 2 weeks f age and lder wh have had flu symptms fr

More information

ITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child.

ITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child. Acute Immune Thrmbcytpenia Purpura (ITP) Backgrund Primary immune thrmbcytpenia (ITP) is an acquired immune mediated disrder characterised by islated thrmbcytpenia, defined as a peripheral bld platelet

More information

/0515 Medication Guide Aripiprazole Tablets

/0515 Medication Guide Aripiprazole Tablets 8415721/0515 Medicatin Guide Aripiprazle Tablets (air-eh-pip-rah-zle) Read this Medicatin Guide befre yu start taking aripiprazle tablets and each time yu get a refill. There may be new infrmatin. This

More information

Forensic Science: Fundamentals & Investigations, 2e Chapter 9. All rights Reserved Cengage/NGL/South-Western 2016

Forensic Science: Fundamentals & Investigations, 2e Chapter 9. All rights Reserved Cengage/NGL/South-Western 2016 1 Frensic Science: Fundamentals & Investigatins, 2e Cengage/NGL/Suth-Western 2016 Frensic Txiclgy By the end f this chapter yu will be able t: 9.1 Prvide examples f drugs, pisns, and txins. 9.2 List factrs

More information

Frequently Asked Questions: IS RT-Q-PCR Testing

Frequently Asked Questions: IS RT-Q-PCR Testing Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld

More information

Meeting Minutes. III. New Business (Slide Presentation is embedded for reference) [slides 3-47] May 2011 DMRAB Presentation PUBLIC C

Meeting Minutes. III. New Business (Slide Presentation is embedded for reference) [slides 3-47] May 2011 DMRAB Presentation PUBLIC C Cmmnwealth f Kentucky Cabinet fr Health and Family Services Department fr Medicaid Services Drug Management Review Advisry Bard Meeting May 12, 2011 Meeting Minutes Vting Members in attendance: Kim Crley,

More information

Creating and Linking Charge Objects

Creating and Linking Charge Objects Overview Charge bject screens are used t maintain cst accunting cdes that agencies use t break ut emplyee time based n wrk perfrmed and leave time while assigned t a specific prject(s). The charge bject

More information

Novel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states.

Novel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states. Nvel methds and appraches fr sensing, evaluating, mdulating and regulating md and emtinal states. 2018 Jy Academic Grant Call fr Prpsals Intrductin The Annual Jy grant initiative aims t prmte and cntribute

More information

Evaluation of a Shared Decision Making Intervention between Patients and Providers to Improve Menopause Health Outcomes: Issue Brief

Evaluation of a Shared Decision Making Intervention between Patients and Providers to Improve Menopause Health Outcomes: Issue Brief Evaluatin f a Shared Decisin Making Interventin between Patients and Prviders t Imprve Menpause Health Outcmes: Issue Brief Key Findings Tablet technlgy can be successfully incrprated int primary practices

More information

Preventing Suicide: Review of Safety Protocol for Suicidal Students. Maureen Cooper Jamie Anderson

Preventing Suicide: Review of Safety Protocol for Suicidal Students. Maureen Cooper Jamie Anderson Preventing Suicide: Review f Safety Prtcl fr Suicidal Students Maureen Cper Jamie Andersn Fast Facts abut Suicide 2013, students in grades 9-12: 17% seriusly cnsidered attempting suicide in the previus

More information

Drug Class Review: Long-acting muscarinic antagonists (LAMAs) for treatment of chronic obstructive pulmonary disease (COPD)

Drug Class Review: Long-acting muscarinic antagonists (LAMAs) for treatment of chronic obstructive pulmonary disease (COPD) Drug Class Review: Lng-acting muscarinic antagnists (LAMAs) fr treatment f chrnic bstructive pulmnary disease (COPD) Cmprehensive Research Plan: Pharmacepidemilgy Unit April 10 th, 2014 ODPRN Drug Class

More information

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate Package leaflet: Infrmatin fr the user Daceptn 5 mg/ml Slutin fr infusin Apmrphine hydrchlride hemihydrate Read all f this leaflet carefully befre yu start using this medicine because it cntains imprtant

More information

Osteoporosis Fast Facts

Osteoporosis Fast Facts Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased

More information

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for Sublingual or Buccal Administration (CIII)

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for Sublingual or Buccal Administration (CIII) MEDICATION GUIDE SUBOXONE (Sub OX wn) (buprenrphine and nalxne) Sublingual Film fr Sublingual r Buccal Administratin (CIII) IMPORTANT: Keep SUBOXONE sublingual film in a secure place away frm children.

More information

BARNSLEY BUSINESS DELIVERY UNIT COMMUNITY SUBSTANCE MISUSE TEAM

BARNSLEY BUSINESS DELIVERY UNIT COMMUNITY SUBSTANCE MISUSE TEAM 1.0 APPLICABLE TO Barnsley specialist Business Delivery Unit. Cmmunity Alchl & Substance Misuse Team Suth West Yrkshire Partnership NHS Fundatin Trust 2.0 RISK FACTORS Reduced piid tlerance and accidental

More information

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

Part 1 describes the reasoning and recommendations up to node 2 of the algorithm.

Part 1 describes the reasoning and recommendations up to node 2 of the algorithm. Presented by: David Osser, MD Assciate Prfessr f Psychiatry Harvard Medical Schl Dr. Osser has n cnflicts f interest t disclse. This dcument is a summary f selected clinical pearls frm Dr. Osser s presentatin:

More information

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new

More information

Commissioning Policy: South Warwickshire CCG (SWCCG)

Commissioning Policy: South Warwickshire CCG (SWCCG) Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding

More information

Chronic Non Malignant Pain - Strong Opioid Prescribing Guideline and Educational Pack

Chronic Non Malignant Pain - Strong Opioid Prescribing Guideline and Educational Pack Appendix 4G Chrnic Nn Malignant Pain - Strng Opiid Prescribing Guideline and Educatinal Pack Backgrund Opiids have been increasingly prescribed t treat chrnic nn malignant pain. There is evidence frm clinical

More information

Candida March, Ines Smyth, and Maitrayee Mukhopadhyay, 1999, A Guide to Gender-Analysis Frameworks, London: Oxfam Publishing.

Candida March, Ines Smyth, and Maitrayee Mukhopadhyay, 1999, A Guide to Gender-Analysis Frameworks, London: Oxfam Publishing. GENDER ANALYSIS FRAMEWORKS There are many mdels and framewrks. N single framewrk prvides an apprpriate way t address all develpment issues Each mdel reflects a set f assumptins abut what gender means and

More information

A. Catalonia World Health Organization Demonstration Project

A. Catalonia World Health Organization Demonstration Project A. Catalnia Wrld Health Organizatin Demnstratin Prject In 1989, the Health Department f Catalnia (Spain) and the Cancer Unit at the WHO (Geneva) designed and planned a demnstratin prject fr implementatin

More information

MEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV

MEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV MEDICATION GUIDE QSYMIA (Ky sim ee uh) (phentermine and tpiramate extended-release) Capsules CIV Read this Medicatin Guide befre yu start taking Qsymia and each time yu get a refill. There may be new infrmatin.

More information

Seeking and Appraising Evidence

Seeking and Appraising Evidence EWMA Educatinal Develpment Prgramme Curriculum Develpment Prject Educatin Mdule: Seeking and Appraising Evidence Latest review: August 2012 Educatin Mdule: Seeking and Appraising Evidence ABOUT THE EWMA

More information

of Communication and Interactions with Individuals who have Dementia

of Communication and Interactions with Individuals who have Dementia Unit 15: Understanding the Rle f Cmmunicatin and Interactins with Individuals wh have Dementia Unit reference number: H/616/7299 Level: 3 Unit type: Optinal Credit value: 3 Guided learning hurs: 26 Unit

More information

Sub-Topic: Massage for Depression, Anxiety, and Sleep Disorders Level 1 Knowledge: Attain and Comprehend Skills: Observe and Imitate

Sub-Topic: Massage for Depression, Anxiety, and Sleep Disorders Level 1 Knowledge: Attain and Comprehend Skills: Observe and Imitate Nte: Feedback frm prfessin stakehlders n the first draft f the Entry-Level Massage Educatin Blueprint indicated that this sub-tpic was beynd entry-level r unnecessary fr safe and cmpetent practice. The

More information

SURGICAL NOTE. Surgical Recommendations to Optimize Femoral/Iliac Artery Cannulation

SURGICAL NOTE. Surgical Recommendations to Optimize Femoral/Iliac Artery Cannulation SURGICAL NOTE Surgical Recmmendatins t Optimize Femral/Iliac Artery Cannulatin Due t its size, lcatin, and ease f access, the femral artery is frequently used fr bld pressure catheter placement. Less frequently,

More information

Evaluation of Hunter & New England HealthPathways

Evaluation of Hunter & New England HealthPathways Evaluatin f Hunter & New England HealthPathways 2 General Practice & Ambulatry Care Activity General Practice MBS data: In 2013 there were 3.3 millin patient attendances t 730 GPs in the HML regin, a 5.6%

More information

ACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals.

ACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals. 27 March 2014 Prfessr Debra Picne Chief Executive Officer Australian Cmmissin n Safety and Quality in Health Care c/ Ms Jennifer Hill, Senir Prject Officer Level 5, 255 Elizabeth Street SYDNEY NSW 2000

More information

OTHER AND UNSPECIFIED DISORDERS

OTHER AND UNSPECIFIED DISORDERS OPTUM COVERAGE DETERMINATION GUIDELINE OTHER AND UNSPECIFIED DISORDERS Guideline Number: BH727OUD_102017 Effective Date: Octber, 2017 Table f Cntents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

Social Learning Theories

Social Learning Theories Scial Learning Theries - Careful scientific prcedures and methdlgy that characterize the behaviurist apprach Albert Bandura - Brn in small twn Alberta - Plish decent - Only sn with 5 sisters - Interested

More information

NUCYNTA ER (tapentadol extended-release tablets) Fact Sheet

NUCYNTA ER (tapentadol extended-release tablets) Fact Sheet NUCYNTA ER (tapentadl extended-release tablets) Fact Sheet What is NUCYNTA ER (prnunced 'new-sinn-tah')? NUCYNTA ER (tapentadl extended-release tablets), an ral analgesic taken twice daily, is nw apprved

More information

CDC Influenza Division Key Points November 7, 2014

CDC Influenza Division Key Points November 7, 2014 In this dcument: Summary Key Messages FluView Activity Update LAIV Effectiveness and Vaccinatin f Children H3N2 Match and Vaccinatin Vaccine Supply Summary Key Messages This week s FluView reprt indicates

More information

For our protection, we require verification that you have received this notice. Therefore, please sign below.

For our protection, we require verification that you have received this notice. Therefore, please sign below. PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults

More information